# Clinical Cases: Hemostasis and Thrombosis

## Case 1: Deep Vein Thrombosis - Virchow's Triad in Action

### Patient Presentation
**Demographics:** 58-year-old female

**Chief Complaint:** Left leg swelling and pain for 3 days

**History of Present Illness:**
A 58-year-old female presents with progressive swelling and pain in her left calf over the past 3 days. She reports that the discomfort started after returning from an 8-hour transatlantic flight 5 days ago. She describes a dull, aching pain that worsens with walking and when standing. She notes that her left calf appears larger than the right. She has a history of breast cancer treated with tamoxifen for the past 2 years.

**Physical Examination:**
- Vital Signs: BP 128/78 mmHg, HR 88 bpm, RR 16/min, SpO2 98% on room air, Temp 37.2C
- General: Mild distress due to leg discomfort
- Left Lower Extremity:
  - Calf circumference 4 cm greater than right
  - Pitting edema to mid-calf
  - Warmth and erythema over posterior calf
  - Tenderness along deep venous distribution
  - Positive Homans sign (calf pain with dorsiflexion)
- Right Lower Extremity: Normal

### Workup
- **Wells Score for DVT:** 3 points (active cancer +1, calf swelling >3cm +1, pitting edema +1) - Moderate probability
- **D-dimer:** 1.8 mcg/mL (elevated, normal <0.5)
- **Compression Ultrasonography:**
  - Non-compressible left popliteal vein
  - Echogenic material within vein lumen
  - Absent color Doppler flow
  - Left femoral vein also involved
- **Labs:**
  - CBC: WBC 8.2, Hgb 12.4, Plt 245
  - PT/INR: 12.1 sec / 1.0
  - aPTT: 28 sec

### Diagnosis
**Acute proximal deep vein thrombosis of the left lower extremity (femoral and popliteal veins)**

*Hemostasis and Thrombosis Correlation:*

**Virchow's Triad Analysis:**

1. **Stasis:**
   - 8-hour flight with prolonged immobility
   - Venous pooling in dependent lower extremities
   - Stagnant blood allows coagulation factor accumulation
   - Prevents dilution and clearance of activated factors

2. **Endothelial Injury:**
   - Prolonged venous distension damages endothelium
   - Loss of antithrombotic endothelial surface
   - Exposure of subendothelial tissue factor
   - Release of von Willebrand factor

3. **Hypercoagulability:**
   - Active malignancy (breast cancer)
   - Tamoxifen therapy (estrogen-like effects)
   - Cancer produces procoagulant factors
   - Tissue factor expression by tumor cells

**Why D-dimer is elevated:**
- D-dimer is a fibrin degradation product
- Indicates active fibrinolysis of cross-linked fibrin
- High sensitivity but low specificity for DVT
- Negative D-dimer excludes DVT in low-probability patients

**Coagulation Cascade Activation:**
1. Tissue factor exposure initiates extrinsic pathway
2. Factor VII activation leads to factor X activation
3. Thrombin generation converts fibrinogen to fibrin
4. Factor XIII cross-links fibrin (stable clot)
5. Plasmin gradually degrades fibrin (produces D-dimer)

**Why proximal DVT is concerning:**
- Higher risk of embolization to pulmonary circulation
- Large thrombus burden
- Greater risk of post-thrombotic syndrome

### Treatment
1. **Anticoagulation (immediate):**
   - Rivaroxaban 15 mg BID for 21 days, then 20 mg daily
   - Alternative: Enoxaparin bridge to warfarin (INR goal 2-3)
2. **Duration:** Extended anticoagulation (cancer-associated)
   - LMWH or DOAC preferred over warfarin in malignancy
3. **Compression stockings:** 30-40 mmHg for post-thrombotic syndrome prevention
4. **Activity:** Early ambulation with anticoagulation
5. **Monitor for PE symptoms:** Dyspnea, chest pain, tachycardia
6. **Cancer follow-up:** Continue surveillance

### Clinical Image
![Deep Vein Thrombosis](case_01_image.jpg)

**Image Description:** Clinical photograph showing unilateral left lower extremity swelling consistent with deep vein thrombosis. Note the visible edema and increased circumference of the affected leg compared to the contralateral limb.

**Source:** Wikimedia Commons - Deep vein thrombosis of the right leg
**License:** CC BY-SA 4.0
**URL:** https://commons.wikimedia.org/wiki/File:Deep_vein_thrombosis_of_the_right_leg.jpg

---

## Case 2: Pulmonary Embolism with Hemodynamic Compromise

### Patient Presentation
**Demographics:** 45-year-old male

**Chief Complaint:** Sudden onset of severe shortness of breath and near-syncope

**History of Present Illness:**
A 45-year-old male with recent arthroscopic knee surgery 10 days ago presents with sudden onset of severe dyspnea and near-syncope that occurred while walking to the bathroom. He describes sharp, pleuritic chest pain on the right side. He has been relatively immobile since surgery due to pain. He reports no prior episodes of blood clots. He noticed mild right calf swelling yesterday but attributed it to the surgery.

**Physical Examination:**
- Vital Signs: BP 88/60 mmHg, HR 118 bpm, RR 28/min, SpO2 88% on room air
- General: Anxious, diaphoretic, in moderate respiratory distress
- Cardiovascular: Tachycardic, loud P2, right ventricular heave, elevated JVP
- Lungs: Clear to auscultation bilaterally
- Right Lower Extremity: Mild calf swelling, tenderness

### Workup
- **ECG:**
  - Sinus tachycardia, 118 bpm
  - S1Q3T3 pattern (deep S in lead I, Q wave and inverted T in lead III)
  - Right axis deviation
  - T wave inversions V1-V4 (RV strain)
- **Labs:**
  - D-dimer: 8.4 mcg/mL (markedly elevated)
  - Troponin I: 0.48 ng/mL (elevated - RV strain)
  - BNP: 680 pg/mL (elevated)
  - ABG: pH 7.48, pCO2 28, pO2 58, HCO3 22 (respiratory alkalosis, hypoxemia)
- **CT Pulmonary Angiography:**
  - Large saddle embolus at main pulmonary artery bifurcation
  - Bilateral lobar and segmental emboli
  - RV:LV ratio 1.4 (RV dilation)
- **Echocardiogram:**
  - Dilated RV with hypokinesis
  - McConnell sign (RV free wall akinesis with apical sparing)
  - D-shaped LV (septal flattening)
  - Moderate tricuspid regurgitation, PASP 55 mmHg

### Diagnosis
**Submassive (intermediate-high risk) pulmonary embolism with right ventricular dysfunction**

*Hemostasis and Thrombosis Correlation:*

**Pathophysiology of PE:**

1. **Thrombus Origin:**
   - Originated from right calf DVT
   - Dislodged and embolized through venous system
   - Traveled through right heart to pulmonary circulation
   - Lodged at bifurcation (saddle embolus)

2. **Mechanical Obstruction:**
   - Large clot burden obstructs pulmonary arteries
   - Acute increase in pulmonary vascular resistance
   - Right ventricle faces sudden pressure overload
   - RV cannot acutely handle increased afterload

3. **Vasoactive Mediator Release:**
   - Platelet-derived serotonin causes vasoconstriction
   - Thromboxane A2 further increases PVR
   - Additional pulmonary vasoconstriction beyond mechanical obstruction

4. **Right Heart Failure Cascade:**
   - RV dilation to maintain output (Frank-Starling)
   - Septal shift compromises LV filling
   - Reduced cardiac output and hypotension
   - RV ischemia from increased wall stress and reduced coronary perfusion

**Why hypoxemia occurs:**
- V/Q mismatch: perfused lung receiving ventilation, occluded areas not perfused
- Increased dead space ventilation
- Right-to-left shunt if foramen ovale opens from elevated RA pressure

**Risk Stratification:**
- Hemodynamically unstable = High-risk (massive) PE
- RV dysfunction + elevated biomarkers = Intermediate-high risk
- This patient: Submassive with borderline BP

**Coagulation System Activation:**
- Recent surgery caused tissue factor release
- Immobility caused venous stasis
- Classic post-operative hypercoagulable state

### Treatment
1. **Immediate stabilization:**
   - IV fluid bolus (cautious - avoid RV overload)
   - Supplemental oxygen (high-flow)
   - Vasopressors if persistent hypotension (norepinephrine)
2. **Anticoagulation:**
   - Unfractionated heparin IV (preferred for potential intervention)
   - 80 units/kg bolus, then 18 units/kg/hr infusion
   - Target aPTT 60-80 seconds
3. **Consider systemic thrombolysis:**
   - Given borderline hemodynamics and RV dysfunction
   - Alteplase 100 mg over 2 hours if deterioration
4. **Alternative: Catheter-directed therapy**
   - Catheter-directed thrombolysis
   - Mechanical thrombectomy
5. **Transition to oral anticoagulation:**
   - After stabilization, minimum 3 months
   - Provoked PE (surgery) - 3 months may suffice
6. **IVC filter:** Only if anticoagulation contraindicated

### Clinical Pearl
**Understanding the Hemostatic Balance:**
This case demonstrates how the protective hemostatic system (designed to prevent bleeding after injury) can become pathological when Virchow's triad elements converge. The coagulation cascade that normally stops bleeding after surgery instead formed a life-threatening venous clot that embolized to the lungs.

**Key Hemostasis Concepts Illustrated:**
- Primary hemostasis (platelet plug) and secondary hemostasis (fibrin) both contribute to venous thrombi
- Venous thrombi are "red clots" - rich in fibrin and trapped RBCs
- D-dimer elevation reflects ongoing fibrinolysis attempting to dissolve the clot
- Anticoagulation prevents clot propagation while endogenous fibrinolysis resolves existing thrombus
